November 16th, 2020
Varifarma is proud to announce our incursion into the fields of NEUROLOGY, RHEUMATOLOGY and HEPATOLOGY within the Rare Diseases Division. This results from our relentless search for new challenges and better solutions for our patients, a goal that has remained our motivation for over two decades now.
Our products in this line are JANVAX® for Rheumatoid Arthritis and Psoriatic Arthritis, FUNOMID® for Relapsing-Remitting Multiple Sclerosis, EMULIMOD® for Multiple Sclerosis, and LENVATIB® for Hepatocellular Carcinoma and Differentiated Thyroid Cancer.
Our Rare Diseases team consists of a Pharma Director, an Area Lead and three sales representatives who have been highly trained in these conditions and their treatments and are dedicated to provide healthcare professionals with groundbreaking scientific evidence. Respect, ethics and commitment are the core values that run through our company and depict the everyday efforts of our teams.